Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.

Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.

About

Company description

Hangzhou Minsheng Binjiang Pharma (HMBP) is wholly-owned by Minsheng Pharma (founded in 1926). It obtained US FDA approval in 2011 & 2014 for solid dosage forms. The plant owns one blister line and one bottle line and focuses on generics for regulated markets.

Based on APIs and focused on preparations, the company produces and develops products of high-tech. It produces active pharmaceutical ingredients and four categories of drug formulations . All of the products and facilities have GMP certificates issued by SDA(State Drug Administration).

Quick facts

Sales markets Western Europe; Eastern Europe; Asia; North America; Central/South America
Primary business activity Manufacturer
Affiliated categories: Capsules |Contract Manufacturing |Contract Packaging More

Recently at

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 838 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 742 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 62B56 See our Exhibitor Profile   See full Exhibitor List
Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.

Contact information

Address

Telephone

Website

View all contact information